BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, April 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2022
View Archived Issues
Immune suppressive glycoprotein-targeting MAb reported
Read More
CAP2 is increased in patients with AD and correlates with tau pathology
Read More
PP2B inhibition clears tau toxicity in experimental AD
Read More
Amyloid beta 42 impacts the expression of SPPL2B in AD
Read More
Anc80L65 vector combined with new surgical technique for hearing loss gene therapy
Read More
OLX-07010 shows promising efficacy in mouse models of tauopathy
Read More
TREM2 agonistic MAb attenuates tau burden and neurodegeneration
Read More
Researchers develop new murine model of AD
Read More
Sorrento reports findings with universal chimeric mRNA based COVID-19 vaccine
Read More
ALS Therapy Development Institute patents new compounds for ALS
Read More
Merck & Co. synthesizes new anti-HIV compounds
Read More
MagicMed Industries presents 5-HT2A receptor agonists
Read More
Incyte divulges new JAK2 inhibitors
Read More
Vertex Pharmaceuticals synthesizes new APOL1 inhibitors
Read More
Volastra collaborates with Bristol Myers Squibb to discover and develop oncology drug candidates
Read More
Grant supports Neuromagen's development of AGS-499 for ALS
Read More
Ixaka expands IP portfolio to allow use of TNP gene delivery platform across multiple areas
Read More
